 Controlled clinical trial that foresees the application of the study product for an uninterrupted period of 4 weeks. 4 visits will be performed: a basal visit T0, a short term evaluation 20 minutes after the 1st product application T20min and a long term evaluation after 2 T2 - intermediate visit and 4 T4 - final visit week-treatment. 